-transparent.png){kind=logo}
In seeking analogues of cyclophosphamide (1) having improved antitumor activity by virtue of accelerated formation of the cytotoxic metabolite phosphoramide mustard, cis and trans isomers of 5-fluoro- and 5-chlorocyclophosphamide (9, 10, 11 and 12, respectively) were synthesized by condensation of the appropriate 3-amino-2-halopropan-1-ol (13 or 26) with N,N-bis(2-chloroethyl)phosphoramidic dichloride (14). The metabolism of the halocyclophosphamides by rat liver microsomes was stereoselective; the cis isomers (9 and 11) were poorly metabolized, whereas the trans isomers (10 and 12) were metabolized with efficiency comparable to that of cyclophosphamide. However, there was no evidence that the yield of phosphoramide mustard produced by the trans analogues were significantly greater than that from cyclophosphamide following microsomal 4-hydroxylation. Hence, the halogen substituents did not accelerate beta-elimination of acrolein from the acyclic aldehydo tautomers. As expected, the poorly metabolized cis-5-fluoride (9) had little activity against the ADJ/PC6 tumor in mice. However, the cis-5-chloride (11) was as active as the trans isomer (12) and each had approximately half the therapeutic index of 1. The trans-5-fluoride (10) was much less active, having an ED90 value some 16-fold that of 1.
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
January 1984,
Il Farmaco; edizione scientifica,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
September 2001,
Anesthesiology,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
October 1993,
British journal of cancer,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
February 1971,
Steroids,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
August 1964,
The Journal of biological chemistry,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
May 1978,
Applied and environmental microbiology,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
October 1963,
Journal of lipid research,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
July 1970,
Biochemical pharmacology,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
January 2020,
Frontiers in pharmacology,
A B Foster, and
M Jarman, and
R W Kinas, and
J M van Maanen, and
G N Taylor, and
J L Gaston, and
A Parkin, and
A C Richardson
February 1986,
Chemical & pharmaceutical bulletin,
